Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.
about
Update on Imaging of Ovarian CancerEndometriosis-associated MalignancyNormal and cancer stem cells of the human female reproductive systemData set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal TransitionMicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancerSerous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Development of nanoscale approaches for ovarian cancer therapeutics and diagnosticsThe role of the PTEN/PI3K/Akt pathway on prognosis in epithelial ovarian cancer: a meta-analysisImmunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b.The role of the tumor stroma in ovarian cancer.Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancerAnalyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancerMolecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypesEstrogen biosynthesis and action in ovarian cancer.Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer.Early inflammatory response in epithelial ovarian tumor cyst fluids.Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associationsGlobal miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic markerThree-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma.Prognostic significance of lymphovascular space invasion in epithelial ovarian cancer.FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinomaEarly pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control studyContraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study.Synthesis and evaluation of perfluorooctylbromide nanoparticles modified with a folate receptor for targeting ovarian cancer: in vitro and in vivo experiments.Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy.Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.Molecular staging of gynecological cancer: What is the future?Epithelial-mesenchymal transition in ovarian carcinomaEpigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.Diagnostic and Prognostic Significance of Ki-67 Immunohistochemical Expression in Surface Epithelial Ovarian Carcinoma.'BRCAness' and its implications for platinum action in gynecologic cancer.Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure.
P2860
Q26750610-965164C5-5743-4CAC-8743-5974230B696DQ26768656-C39A1D7D-187B-423A-8636-38D33C36FF17Q26830842-D4D96DB7-CCE1-4E64-8E38-C1A219690BC2Q26852127-F1883F07-2033-429E-B4FD-261186C96E9EQ28071987-45B18BB6-A128-4BDC-9B70-DF3C7AB3DD2AQ28385520-78841BAB-4B26-4C43-968E-9171BADB1EFCQ30235845-454C4F56-B251-40C4-B6F4-468ADAF5A067Q30252854-3E20F273-1805-4272-AC46-00288806EE4DQ30421664-657921F7-5088-4E09-979C-55AEDB2A666AQ33577824-6D0FC10E-1921-4242-84CE-9D54DFC8333AQ33629621-76BB1A7E-3CBF-453C-AEE5-5D61986EB15CQ33633856-36A540C5-B71E-4D95-AFCA-33DE4799081EQ33704050-60B6905C-7762-4049-AA0B-1428A38ED57EQ33787214-E93FED4B-3F44-4B19-92AE-9A5F255FE433Q34199368-2E59D0C5-DC9D-45AC-B62C-2DDA84411C50Q34496401-2AC41832-8157-4426-A462-05C5351692E8Q34528553-B25C8833-65DC-4CCA-9133-E9828F9A9F44Q34807665-02C0D9C5-C0D4-4200-9C4F-A17FC6AB9F0CQ34951783-6C33AC7D-23BC-4AFF-BF2A-0B4A26DD76C6Q34998539-62278C8E-B012-4046-AF13-92FF7F11A032Q35077586-E13B7EDF-EBC7-483E-90CE-D2C0623CA4D2Q35080233-08506EB0-535F-4AF3-BA27-C3B77C948947Q35089974-A40D8A43-FEF7-4194-9C79-8075166F06A8Q35139059-3C345AB5-5E0B-42AA-8A26-431258B5C8BAQ35349142-0BD1EA8C-DFD3-416F-B344-AED1BAE9DFF8Q35419216-75E37BCB-EAB8-4523-BB20-C7AD609EF32AQ35575822-8D621A61-9BCC-45AB-8257-A64F9E1F5A02Q35598117-A3664996-4929-4AAA-B3D3-CC19E0509FDBQ35624957-92AA0F03-F6AC-474B-94F7-F60585AB798CQ35756395-1246DB6B-0D18-419B-905D-799D28DDEDEAQ35820674-68CE6A95-8DF1-4C1B-8BAB-24D5392B1C58Q35857189-75CF34C2-D98D-4705-8918-8A14680689F4Q35940829-C9C118CB-8569-453A-96D6-F844BA7A8EDEQ35971814-D62318F1-D051-47EE-97BE-CD0EABF3B0FDQ36213561-7A8E2BD0-30A6-4DBE-84C6-BC42E026AF97Q36243394-B5CE1CFA-D751-4946-8DB6-D253C5B29E3DQ36245791-D62E1E79-7EB9-466A-A6F6-90D3EA5F9C90Q36338865-33FDD637-DDE4-4666-B2AF-0EEF875F21E8Q36380704-25AC83CA-4E6E-4F33-8054-8868DC923FF7Q36396500-5225FB34-9CC9-4F39-A4F8-153181583D93
P2860
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ovarian carcinomas: five disti ...... clinicopathological features.
@en
Ovarian carcinomas: five disti ...... clinicopathological features.
@nl
type
label
Ovarian carcinomas: five disti ...... clinicopathological features.
@en
Ovarian carcinomas: five disti ...... clinicopathological features.
@nl
prefLabel
Ovarian carcinomas: five disti ...... clinicopathological features.
@en
Ovarian carcinomas: five disti ...... clinicopathological features.
@nl
P2860
P1433
P1476
Ovarian carcinomas: five disti ...... clinicopathological features.
@en
P2093
Jaime Prat
P2860
P2888
P304
P356
10.1007/S00428-012-1203-5
P577
2012-02-10T00:00:00Z